biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > How Low Can It Go?

<< Previous

Bullboard Posts

Next >>

Comment by Aarcoron May 06, 2021 3:17pm

103 Views

Post# 33144108

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How Low Can It Go?

Alright, looks like the supporters of a 10-year failed business plan will remain onboard and loyal to whomever the current management team is to the end. Like a cult.

If you point this out in year 7, and then year 8, year 9, and 10 you are considered a "whiner" by people who either have such low shareholdings as to not be meaningful to them or have infinitely long term timeframes like Buffett.

The same people who "remove people from ignore" to express their complaints to those who complain, is a special kind of hypocritical stupid.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property